Neuberger Berman Group’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $390K | Sell |
|
|||||
|
2025
Q1 | $401K | Sell |
|
|||||
|
2024
Q4 | $952K | Buy |
|
|||||
|
2024
Q3 | $968K | Buy |
|
|||||
|
2024
Q2 | $512K | Sell |
|
|||||
|
2024
Q1 | $664K | Buy |
|
|||||
|
2023
Q4 | $595K | Sell |
|
|||||
|
2023
Q3 | $21M | Buy |
|
|||||
|
2023
Q2 | $22M | Buy |
|
|||||
|
2023
Q1 | $27.7M | Buy |
|
|||||
|
2022
Q4 | $24.3M | Buy |
|
|||||
|
2022
Q3 | $23.9M | Sell |
|
|||||
|
2022
Q2 | $28.6M | Buy |
|
|||||
|
2022
Q1 | $30.8M | Buy |
|
|||||
|
2021
Q4 | $41.1M | Buy |
|
|||||
|
2021
Q3 | $40.2M | Sell |
|
|||||
|
2021
Q2 | $50.6M | Buy |
|
|||||
|
2021
Q1 | $36.5M | Buy |
|
|||||
|
2020
Q4 | $31M | Sell |
|
|||||
|
2020
Q3 | $33.2M | Buy |
|
|||||
|
2020
Q2 | $29.1M | Buy |
|
|||||
|
2020
Q1 | $22.5M | Sell |
|
|||||
|
2019
Q4 | $34.9M | Sell |
|
|||||
|
2019
Q3 | $38.2M | Buy |
|
|||||
|
2019
Q2 | $35.9M | Sell |
|
|||||
|
2019
Q1 | $35.1M | Buy |
|
|||||
|
2018
Q4 | $26.6M | Sell |
|
|||||
|
2018
Q3 | $36.1M | Sell |
|
|||||
|
2018
Q2 | $33.6M | Sell |
|
|||||
|
2018
Q1 | $32.5M | Sell |
|
|||||
|
2017
Q4 | $31.3M | Sell |
|
|||||
|
2017
Q3 | $29.2M | Buy |
|
|||||
|
2017
Q2 | $24.7M | Buy |
|
|||||
|
2017
Q1 | $17.2M | Buy |
|
|||||
|
2016
Q4 | $9.65M | Buy |
|